About BIVSX
Invenomic Fund Super Institutional Class is an actively managed mutual fund specializing in a long-short equity investment strategy. Its primary objective is to achieve long-term capital appreciation by investing in both long and short positions in equity securities, predominantly those traded in U.S. markets. The fund is notable for its flexible approach, enabling the management team to adjust exposure based on market opportunities and macroeconomic outlooks, which can include equities, ETFs, and related derivatives.
Classified within the long-short equity category, the fund often targets small and medium-sized companies, sectors such as technology, communication services, utilities, energy, and financial services. As of its most recent portfolio disclosures, cash positions can be significant, accompanied by concentrated exposures to select equities.
With total assets around $1.2 billion and designed for institutional investors—given its high minimum initial investment requirement—the fund plays a distinctive role in portfolio diversification by aiming to generate returns that are less correlated with traditional equity benchmarks. Its high turnover ratio and expense level reflect active oversight and complex trading strategies, positioning the fund as a sophisticated tool for seeking capital growth while navigating a variety of market conditions.
Fund Family Invenomic
Category Long-Short Equity
Performance Rating Below Average
Risk Rating Above Average
Stock Exchange NASDAQ
Ticker Symbol BIVSX
Share Class Super Institutional Class Shares
Index S&P Composite 1500 TR
BIVSX had a total return of 7.22% in the past year, including dividends. Since the fund's
inception, the average annual return has been 19.06%.
